Neural Correlates of Hypoalgesia Driven by Observation

PHASE2RecruitingINTERVENTIONAL
Enrollment

182

Participants

Timeline

Start Date

November 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
PainVirtual RealityPlacebo
Interventions
DRUG

Naloxone

"4mg of Naloxone will be administered (0.1 mL of 40 mg/ml naloxone solution given intranasally).~A random allocation sequence will be independently generated by the UM Pharmacy. The Principal investigator will call for each experiment."

OTHER

Saline

"Intranasal Normal Saline (0.1 mL 0.9% sodium chloride) will be administered shortly before beginning the fMRI experiment.~A random allocation sequence will be independently generated by the UM Pharmacy. The Principal investigator will call for each experiment."

Trial Locations (1)

21201-1512

RECRUITING

University of Maryland, Baltimore

All Listed Sponsors
lead

University of Maryland, Baltimore

OTHER